GTHP Stock Alert Guided Therapeutics, Inc.

New Post Public Reply Private Reply Replies (0) Message Board

Oct 1, 2013 at 8:00 PM

Guided Therapeutics, Inc. GTHP Company Overview

Stock Message Board http://investorshangout.com/search?q=GTHP&...mp;yt1=Go!

Guided Therapeutics, Inc. GTHP Current Price and Quotes
Last Price 0.63
Previous Close 0.6445 Open 0.64
Daily Range 0.64 - 0.61 52wk Range 0.98 - 0.469
Volume 79,600 Dividend N/A
Average Vol (3m) 109,555 Yield N/A
Guided Therapeutics, Inc. GTHP
Company Information

5835 Peachtree Corners East
Suite D
Norcross, GA 30092

Website: http://www.guidedinc.com
Phone: 770-242-8723
Email: info@guidedinc.com

Guided Therapeutics, Inc. GTHP
Guided Therapeutics, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. The company also owns technology for measuring substances in interstitial fluid, a secondary circulatory system in ...

Guided Therapeutics, Inc. GTHP
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000924515
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. 1992
Employees 21 a/o Dec 31, 2006
Company Officers/Contacts

Mark L. Faupel President, CEO, Secretary
Bill Wells Director, Corp. Comm.
Company Directors

William E. Zachary Chairman
Mark L. Faupel
Ronald W. Hart
John E. Immhoff
Michael C. James
Company Notes

Formerly=SpectRx, Inc. until 5-2008
Service Providers

Auditor/Accountant
UHY LLP
66 State St
Albany, NY, 12207
United States

Legal Counsel
Jones Day
1420 Peachtree st.
Atlanta, GA, 30309
United States

Investor Relations Firm
Not Available

Guided Therapeutics, Inc. GTHP
GTHP Security Details

Share Structure

Market Value1 $42,666,579 a/o Sep 30, 2013
Shares Outstanding 66,201,054 a/o Aug 09, 2013
Float 7,248,000 a/o Apr 09, 2007
Authorized Shares 50,000,000 a/o Apr 09, 2007
Par Value 0.001
Shareholders

Shareholders of Record 224 a/o Mar 27, 2013
Security Notes

New Issue=7-97 2,200,000 shs at $7 by Hambrecht & Quist et al.
Short Selling Data

Short Interest 356,907 (1.9%)
Sep 13, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Computershare Investor Services LLC

Guided Therapeutics, Inc. GTHP Recent News

Sept 9, 2013 Guided Therapeutics Receives Additional Questions from FDA for LuViva(R) Advanced Cervical Scan
Aug 15, 2013 Guided Therapeutics Reports Second Quarter 2013 Results
Aug 5, 2013 Guided Therapeutics to Report Second Quarter 2013 Results and Hold Conference Call
Jul 3, 2013 Guided Therapeutics Continues to Await Update from FDA on Its PMA Application for LuViva(R) Advanced Cervical Scan
Jul 2, 2013 CORRECTING and REPLACING Guided Therapeutics and I.T.E.M. Medical Technologies Group Announce Turkish Ministry of Health Sponsored Cervical Cancer Prevention Program Involving the LuViva(R) Advanced Cervical Scan
Jul 2, 2013 Guided Therapeutics and I.T.E.M. Medical Technologies Group Announce Turkish Ministry of Health Sponsored Cervical Cancer Prevention Program Involving the LuViva(R) Advanced Cervical Scan

Guided Therapeutics, Inc. GTHP Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 3,410 3,622 3,364 1,550
Cost of Revenue 117 106 - -
Gross Profit 3,293 3,516 3,364 1,550
Operating Expenses

Research and Development 3,227 2,779 1,805 1,409
Sales, General and Admin. 4,347 7,493 3,180 2,001
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,281) (6,756) (1,621) (1,860)
Income From Continuing Operations

Add'l Income/Expense Items - 192 2 (369)
Earnings Before Interest and Tax (4,281) (6,564) (1,619) (2,229)
Interest Expense 72 80 1,227 3,983
Earnings Before Tax (4,353) (6,644) (2,846) (6,212)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,353) (6,644) (2,846) (6,212)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,353) (6,644) (2,846) (6,212)
Preferred Stock and Other Adjustments - - (1,700) (223)
Net Income Applicable to Common Shareholders (4,353) (6,644) (4,546) (6,435)

GTHP Guided Therapeutics, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GTHP&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GTHP/quote
Stock Chart http://www.otcmarkets.com/stock/GTHP/chart
Company Info http://www.otcmarkets.com/stock/GTHP/company-info
Recent News http://www.otcmarkets.com/stock/GTHP/news
Financials http://www.otcmarkets.com/stock/GTHP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GTHP/filings
Short Sales http://www.otcmarkets.com/stock/GTHP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GTHP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GTHP/research
Summary http://finance.yahoo.com/q?s=GTHP
Historical Prices http://finance.yahoo.com/q/hp?s=GTHP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GTHP
Basic Chart http://finance.yahoo.com/q/bc?s=GTHP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GTHP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GTHP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GTHP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GTHP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GTHP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GTHP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GTHP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GTHP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GTHP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GTHP
Balance Sheet http://finance.yahoo.com/q/bs?s=GTHP
Cash Flow http://finance.yahoo.com/q/cf?s=GTHP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GTHP
Market Watch http://www.marketwatch.com/investing/stock/GTHP
Bloomberg http://www.bloomberg.com/quote/GTHP:US
Morningstar http://quotes.morningstar.com/stock/s?t=GTHP
Bussinessweek http://investing.businessweek.com/research/st...icker=GTHP
Barchart http://www.barchart.com/quotes/stocks/GTHP
OTC Short Report http://otcshortreport.com/index.php?index=GTHP
Investopedia http://www.investopedia.com/markets/stocks/GTHP/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Voter Events by Valley Community Healthcare Aim to Empower

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Innventure Faces Major Lawsuit Over Misleading Investors

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Masimo's smartSET™ Revolutionizes Patient Monitoring

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Hyliion Class Action Deadline Nears for Investors

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

LG OLED evo W6: UAE Roadshow Starts with a Bang

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...